Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
T cell-intrinsic ASC critically promotes TH17-mediated experimental autoimmune encephalomyelitis.
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
IFN-γ Signaling to Astrocytes Protects from Autoimmune Mediated Neurological Disability.
Functional role of TRP channels in modulating ER stress and Autophagy.
Central nervous system lymphoma associated with natalizumab.
Novartis updates US label on Gilenya® following discussions with the FDA
The natural course of clinically isolated syndrome in pediatric patients.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
Autoimmunity: Rubbing salt in the wound.
[Cannabinoid drugs for neurological diseases: what is behind?].
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis.
Painful Tonic Spasm in Neuromyelitis Optica: Incidence, Diagnostic Utility, and Clinical Characteristics.
The biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?
[Multiple sclerosis: new approaches to comprehensive treatment and rehabilitation using the method of reflexology].
Development of a Computer-aided Diagnostic System for Detecting Multiple Sclerosis Using Magnetic Resonance Images.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.
Pages
« first
‹ previous
…
130
131
132
133
134
135
136
137
138
…
next ›
last »